Gene therapies offer the potential to provide significant—and possibly curative—benefits to patients with genetic or acquired diseases. Through either the direct expression of a therapeutic protein or by restoring the expression of an under-expressed protein, gene therapy uses vectors for gene-based drugs and therapeutic loads to the patient.

Maintaining the integrity and activity of the gene therapy product during upstream and downstream purification through final fill is endlessly complex. Avantor® offers a broad range of solutions to help you develop gene therapies that can reach patients faster—from cell culture components, fermentation media and supplements, growth factors, reagents and excipients and single-use use products to enable aseptic fluid transfer and closed-system cell culture.

Gene therapy workflow solutions

Upstream processing: Optimal generation of gene therapy vectors is achieved with Avantor’s non-viral transfection and viral transduction products. Our culture systems support processes development, scale-up and full manufacturing. We offer a variety of transfection and electroporation products, viral vector generation kits, animal sera, single-use products and sterile cell factories.

Downstream purification: Avantor J.T.Baker® brand BAKERBOND™ chromatography resins have been used successfully in commercial and clinical manufacturing of protein therapeutics. Backed by more than 30 years of chromatography experience, developed products and services, we also provide services including column packing, process development support, custom chromatography resins and column cleaning and storage recommendations.

Final fill: Progressing from the drug substance to the final injectable drug product requires final packaging vials and stoppers, as well as a broad range of excipients that meet a number of stringent quality requirements.  

Environmental control: Maintaining controlled aseptic conditions during the manufacturing or down packing process is part of managing your risk. We offer products from industry-leading manufacturers and support from our teams of specialists with technical and industry experience who can recommend the best solutions to meet your needs.

Products to help advance gene therapy manufacturing

Start optimizing your process performance with our innovative products and solutions for gene therapy production:

To find a channel partner in your region, please click here.

Opportunities and challenges in cell and gene therapy development

Q&A interview with Ger Brophy, Executive Vice President for Biopharma Production at Avantor

Related resources